Atlas Trials

Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.

Clinical trial NCT07372365 · RECRUITING

Trial details

NCT number
NCT07372365
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Marginal Zone Lymphoma (MZL)
Start date
2025-10-24
Primary completion
2028-04-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.